300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Armenia
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Chuo Shinkin Venture Capital

VC Fund

Chuo Shinkin Venture Capital is a venture fund of Kyoto Chuo Shinkin Bank

Total investments:
9
Last investment:
Lead investor:
0%

Last updated:

Industries Chuo Shinkin Venture Capital invests in

MedicalHealth CareLife ScienceManufacturingGPS

Stages Chuo Shinkin Venture Capital invests in

Series ASeries BVenture - Series UnknownSeed

Countries Chuo Shinkin Venture Capital invests in

Japan

Round sizes

Series A $1.3M–$8.1MSeries B $4M–$12MVenture - Series Unknown $183k–$2.2M

Round size

Series A
$1.3M–$8.1M
Series B
$4M–$12M
Venture - Series Unknown
$183k–$2.2M

Investment Focus

Industry

  • Medical 2 (22%)
  • Health Care 2 (22%)
  • Life Science 2 (22%)
  • Manufacturing 2 (22%)
  • GPS 1 (11%)
See all 22 industries →

Stage

  • Series A 4 (44%)
  • Series B 2 (22%)
  • Venture - Series Unknown 2 (22%)
  • Seed 1 (11%)

Investments

CompanyDescriptionRoundLinks
HACARUS HACARUS
HACARUS is a provider of Explainable Lightweight AI Tools, backed by Miyako Capital (Kyoto University) among others. Its solutions are used in the Medical and Manufacturing fields to enable humans to make better, faster and more reliable decisions, based on AI driven insights. Hacarus' proprietary AI engine is built using Sparse Modeling, anAI method that understands data like a human would - by its unique key features and is far more resource, time and energy efficient when compared to Deep Learning. $12.4M / Series B / Nov 16, 2020
Regional Fish Regional Fish
Regional Fish provides seed, seedlings, aquaculture methods and fisheries services. $3.8M / Series A / Aug 31, 2020
Thyas Thyas
Thyas Co. Ltd. provides preparations of regenerative immunocell therapy for cancer and infection. $2.2M / Venture - Series Unknown / Nov 20, 2019
Space Power Technologies Space Power Technologies
Space Power Technologies (SPT) was founded in 2019 as Japan's first start-up for “Spatial Transmission Wireless Power Transmission (WPT)”. We will harmonize elemental technologies cultivated through academics with people and society, and solve social issues related to power supply. Seed / Sep 04, 2019
Atomis Atomis
Atomis provides global solutions for precisely controlling gases. Its core technology, porous coordination polymers (PCPs; also known as metal-organic frameworks (MOFs)), is based on research developed by Distinguished Professor Susumu Kitagawa at the Institute for Advanced Study at Kyoto University. It aims not only to provide solutions such asthe optimization for manufacturing processes of PCPs but to also develop applications that provide innovative value using these materials.It was founded by Masakazu Higuchi in 2015 and is headquartered in Kyoto, Japan. $3.2M / Series A / Jul 01, 2019
AlphaNavi Pharma AlphaNavi Pharma
AlphaNavi Pharma specializes in the research and development of new drugs. $8.1M / Series A / Apr 05, 2019
AFI Technology AFI Technology
AFI Technology develops and supplies microbial testing systems and particle separation technologies for applications in biotechnology, pharmaceuticals, and quality control. The company provides equipment such as the PixeeMo-nX, which enables rapid detection and quantification of viable microorganisms using automated imaging and analysis functions.Its technology separates and captures microorganisms from complex samples through electrical and fluid control methods, allowing detailed measurement and evaluation. AFI Technology also supports processes involving concentration and recovery of microorganisms for further study, including samples that are difficult to culture. The company focuses on integrating analytical systems with research and production workflows that require precise microbial assessment. $4M / Series B / Feb 13, 2018
RegCell RegCell
RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer . $183K / Venture - Series Unknown / Aug 04, 2017
Stroly Stroly
Stroly is a map platform that allows you to experience and share the diverse stories within the place. With the birth of smartphones and map apps, it became easier to acknowledge their locations. The map apps function as tools to provide accurate information about your destination and your current location. However, the information provided by appscannot share the stories of how the people living there have felt and thought throughout the time. Also, it is hard to imagine the shape of the city and what kind of stories will be created in the future. $1.3M / Series A / May 17, 2017

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Armenia
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Chuo Shinkin Venture Capital invest in?

Chuo Shinkin Venture Capital invests primarily in Medical, Health Care and Life Science startups, most often at Series A and Series B stage. Most of the 9 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Chuo Shinkin Venture Capital's check size?

Chuo Shinkin Venture Capital typically joins rounds of $1.3M–$8.1M at Series A, $4M–$12M at Series B and $183k–$2.2M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chuo Shinkin Venture Capital participates in.

When did Chuo Shinkin Venture Capital last invest?

The most recent investment recorded for Chuo Shinkin Venture Capital closed in Nov 2020. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Chuo Shinkin Venture Capital Find emails